威高骨科
(688161)
| 流通市值：102.28亿 | | | 总市值：102.28亿 |
| 流通股本：4.00亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,083,278,467.47 | 750,539,867.68 | 347,912,613.72 | 1,283,549,219.69 |
| 营业收入 | 1,083,278,467.47 | 750,539,867.68 | 347,912,613.72 | 1,283,549,219.69 |
| 二、营业总成本 | 909,362,061.83 | 650,646,993.9 | 317,060,839.41 | 1,174,225,736.56 |
| 营业成本 | 382,759,040.67 | 269,648,572.74 | 141,056,807.61 | 429,703,688.01 |
| 税金及附加 | 12,457,012.38 | 8,247,860.39 | 3,124,704.18 | 18,528,212.62 |
| 销售费用 | 371,892,305.06 | 278,608,139.32 | 132,945,293.21 | 560,823,902.88 |
| 管理费用 | 64,551,696.77 | 40,288,736.85 | 16,539,976.16 | 60,991,061.92 |
| 研发费用 | 91,157,022.54 | 63,648,262.46 | 29,532,012.18 | 130,195,414.65 |
| 财务费用 | -13,455,015.59 | -9,794,577.86 | -6,137,953.93 | -26,016,543.52 |
| 其中:利息费用 | 223,771 | 157,389.97 | 159,416.85 | 945,769.88 |
| 其中:利息收入 | 15,616,496.92 | 10,868,762.35 | 5,821,610.48 | 28,421,870.17 |
| 加:公允价值变动收益 | 88,219.18 | - | - | 126,121 |
| 加:投资收益 | 19,653,093.07 | 14,447,824.97 | 6,465,333.11 | 27,690,444.2 |
| 资产处置收益 | -124,113.08 | -124,113.08 | -12,638.05 | 16,107.73 |
| 资产减值损失(新) | -12,488,219.36 | -12,234,957.87 | -186,557.83 | -30,766,130.78 |
| 信用减值损失(新) | 10,335,866.43 | 3,476,608.28 | 3,012,079.43 | 16,042,934.93 |
| 其他收益 | 9,228,735.98 | 6,792,599.71 | 1,403,597.89 | 8,458,798.39 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 200,609,987.86 | 112,250,835.79 | 41,533,588.86 | 130,891,758.6 |
| 加:营业外收入 | 307,683.81 | 267,904.21 | 95,487.51 | 1,235,296.26 |
| 减:营业外支出 | 860,676.51 | 839,470.45 | 151,566.67 | 503,569.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 200,056,995.16 | 111,679,269.55 | 41,477,509.7 | 131,623,485.51 |
| 减:所得税费用 | 31,630,383.5 | 15,510,567.52 | 5,625,726.47 | 18,530,911.52 |
| 六、净利润 | 168,426,611.66 | 96,168,702.03 | 35,851,783.23 | 113,092,573.99 |
| 持续经营净利润 | 168,426,611.66 | 96,168,702.03 | 35,851,783.23 | 113,092,573.99 |
| 归属于母公司股东的净利润 | 164,293,158.99 | 93,129,877.9 | 34,905,665.79 | 112,315,000.06 |
| 少数股东损益 | 4,133,452.67 | 3,038,824.13 | 946,117.44 | 777,573.93 |
| (一)基本每股收益 | 0.41 | 0.23 | 0.09 | 0.28 |
| (二)稀释每股收益 | 0.41 | 0.23 | 0.09 | 0.28 |
| 九、综合收益总额 | 168,426,611.66 | 96,168,702.03 | 35,851,783.23 | 113,092,573.99 |
| 归属于母公司股东的综合收益总额 | 164,293,158.99 | 93,129,877.9 | 34,905,665.79 | 112,315,000.06 |
| 归属于少数股东的综合收益总额 | 4,133,452.67 | 3,038,824.13 | 946,117.44 | 777,573.93 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-03-27 |
| 审计意见(境内) | | | | 标准无保留意见 |